Immunogenicity and Safety of the Purified Vero Rabies Vaccine - Serum Free (VRVg) in Comparison With the Human Diploid Cell Vaccine, Imovax Rabies in a Pre-exposure Prophylaxis Regimen in Healthy Children and Adolescents Aged 2 to 17 Years
Phase of Trial: Phase II
Latest Information Update: 27 Apr 2017
At a glance
- Drugs Rabies vaccine (Primary)
- Indications Rabies
- Focus Therapeutic Use
- Sponsors Sanofi
- 02 Sep 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 05 Mar 2015 According to the ClinicalTrials.gov record, planned end date changed from 1 Dec 2014 to 1 Jun 2015.
- 13 Mar 2014 Planned End Date changed from 1 Jun 2014 to 1 Dec 2014 as reported by ClinicalTrials.gov